JIUDIAN PHARMACEUTICAL announced that the company has acquired all developed results and corresponding intellectual property rights of JIJ02 gel from Chengdu Peide Biopharmaceutical Co., Ltd. for 90 million yuan, and signed the "Technology Transfer Contract." The drug name is JIJ02 gel, registered as Class 1 chemical drug, with the intended indication for common acne. The company's acquisition of the clinical trial approval notice for this drug will not have a significant impact on the company's financial condition and operating performance